+987.9%
MRNA vs GME
+15.0%
+973.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GME | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.6% | +9.5% | +11.1% |
| 7D | +20.6% | +7.8% | +12.9% | +16.1% |
| 30D | +27.1% | -0.4% | +27.5% | +28.7% |
| 3M | +353.4% | +30.9% | +322.5% | +302.1% |
| 6M | +446.3% | +5.5% | +440.8% | +420.9% |
| YTD | +776.2% | +25.2% | +751.0% | +652.9% |
| 1Y | +987.9% | +14.4% | +973.5% | +849.9% |
| All | +987.9% | +15.0% | +973.0% | +849.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GME.
Daily Out/Under-Performance
Portfolio return minus GME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling